The information contained herein, including statistics, market updates, opportunities, risks, and recommendations regarding semaglutide (generic versions of Ozempic/Wegovy) and related GLP-1 drugs, is based on publicly available reports, studies, and news as of March 2026
These medications, glucagon-like peptide receptor agonists (GLP-1s), target receptors in the brain to create their appetite-suppressing effects
Can Mounjaro (tirzepatide) and Repatha (evolocumab) be administered on the same day in a patient with type 2 diabetes and high cholesterol, or should they be spaced out to minimize potential interactions?
Research-grade peptides done Research peptides, handled with care